418763-57-2

Upstream product

• 418763-54-9 (2-O-benzoyl-4,6-O-benzylidene-3-O-levulinoyl-β-D-galactopyranosyl)-(1->4)-[2,3,4-tri-O-benzyl-α-L-fucopyranosyl-(1->3)]-2-O-acetyl-6-O-benzyl-N-benzyloxycarbonyl-1,5-dideoxy-1,5-imino-D-glucitol 
• 173273-81-9 (2-O-benzoyl-3-O-levulinoyl-β-D-galactopyranosyl)-(1->4)-[(2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-(1->3)]-2-O-acetyl-6-O-benzyl-N-benzyloxycarbonyl-1,5-dideoxy-1,5-imino-D-glucitol 
• 178962-70-4 methyl 2-O-benzoyl-4,6-O-benzylidene-3-O-levulinoyl-1-thio-β-D-galactopyranoside 
• 123-72-8 butyraldehyde 
• 418763-56-1 (2-O-benzoyl-3-O-levulinoyl-β-D-galactopyranosyl)-(1->4)-[α-L-fucopyranosyl-(1->3)]-2-O-acetyl-1,5-dideoxy-1,5-imino-D-glucitol 

Downstream Products

• 418763-59-4 (4,6-di-O-acetyl-2-O-benzoyl-3-O-levulinoyl-β-D-galactopyranosyl)-(1->4)-[(2,3,4-tri-O-acetyl-α-L-fucopyranosyl)-(1->3)]-2,6-di-O-acetyl-N-butyl-1,5-dideoxy-1,5-imino-D-glucitol 

Relevant academic research and scientific papers

Synthesis of sialyl- and sulfo-Lex/Lea analogs containing N-alkyl-1-deoxynojirimycin as potential selectin blockers

A series of novel sialyl- and sulfo-Lex/Lea oligosaccharides containing N-alkyl-1-deoxynojirimycin as potential selectin blockers have systematically been synthesized via the suitably protected intermediates containing N-benzyloxycar